IntelliCyt Corporation, a leading provider of high throughput cell- and bead-based screening solutions, announces the shipment of iQue® Screener HD. Breaking new ground in the miniaturization of suspension assay formats, the iQue Screener HD is the first and only commercially available instrument that can process, analyze, and visualize data from 1536 well microplates. The company also announces the availability of new MultiCyt® reagents to profile cell health and monitor cell function.
KFx Medical Corporation announced that it has entered into a license agreement with DePuy Mitek, LLC (“Mitek”) relating to its patents used in knotless double row rotator cuff repair.
Esperion Therapeutics, Inc. (Nasdaq: ESPR), a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers, announced dosing of the first patient in its Phase 2 clinical study of ETC-1002 in patients with hypercholesterolemia and hypertension, ETC-1002-014. The company expects to announce top-line results from the study in the second quarter of 2015.
ArborMetrix, Inc., a leading provider of cloud-based healthcare analytics solutions, and the Michigan Health & Hospital Association (MHA) Keystone Center today announced a strategic partnership to use the ArborMetrix platform to identify care improvement and cost-reduction opportunities in hospitals across the state.